Premanath M, Basavanagowdappa H, Mahesh M, Babu M Suresh
Senior Consultant in Internal Medicine and Diabetes, JSS Medical College, JSS University, Mysuru, Karnataka, India.
Professor of Medicine and Principal, JSS Medical College, JSS University, Mysuru, Karnataka, India.
Indian J Endocrinol Metab. 2017 Mar-Apr;21(2):308-315. doi: 10.4103/ijem.IJEM_418_16.
To assess the occurrence of diabetes in obese nondiabetic patients over a 3-year follow-up period with a correlative analysis of visceral fat (VF), fasting insulin levels, (FILs) and insulin resistance (IR).
Thirty-seven obese and nineteen nonobese nondiabetics of our previous study, Mysore Visceral Adiposity in Diabetes were followed for the next 3 years. Their blood pressure, body mass index, waist circumference (WC), fasting blood sugar (FBS), FIL, lipid profile and subcutaneous fat (SCF), and VF measurement by US method were repeated every 6 months for the next 3 years. The findings were analyzed with appropriate statistical methods.
Twenty-three obese and 18 nonobese nondiabetics completed the study. There were 17 dropouts. The changes in the physical and biochemical characteristics of the two groups before and after the study were not significant. SCF had no correlation with IR whereas VF correlated with FIL and IR. There were three diabetics in the obese group and two from the control group at the end of the study. There were 12 impaired glucose tolerance (IGT) in the test group and 2 in the control group. Those who developed diabetes had higher VF, WC, FBS, FIL, and IR. Those who showed IGT also had these at higher levels compared to others. There was no change in the VF at the end of the study.
This follow-up study on South Indians has shown that VF is a significant risk factor for the development of IR. IR can develop without any increase in the volume of the VF, is the essential finding of this study. SCF has not shown any significant relationship with IR. We recommend FBS and FIL in all the obese nondiabetics to calculate IR, which has given much insight in the development of IGT and diabetes. Large multicentric, longitudinal studies are required to establish the cause of IR.
通过对内脏脂肪(VF)、空腹胰岛素水平(FILs)和胰岛素抵抗(IR)进行相关性分析,评估肥胖非糖尿病患者在3年随访期内糖尿病的发生情况。
对我们之前研究“迈索尔糖尿病内脏肥胖”中的37名肥胖非糖尿病患者和19名非肥胖非糖尿病患者进行了为期3年的随访。在接下来的3年里,每6个月重复测量他们的血压、体重指数、腰围(WC)、空腹血糖(FBS)、FIL、血脂谱、皮下脂肪(SCF),并采用超声法测量VF。采用适当的统计方法对研究结果进行分析。
23名肥胖非糖尿病患者和18名非肥胖非糖尿病患者完成了研究。有17名退出者。研究前后两组的身体和生化特征变化不显著。SCF与IR无相关性,而VF与FIL和IR相关。研究结束时,肥胖组有3名糖尿病患者,对照组有2名。试验组有12例糖耐量受损(IGT),对照组有2例。发生糖尿病的患者VF、WC、FBS、FIL和IR较高。出现IGT的患者这些指标也高于其他人。研究结束时VF没有变化。
这项针对南印度人的随访研究表明,VF是发生IR的重要危险因素。IR可以在VF体积没有任何增加的情况下发生,这是本研究的重要发现。SCF与IR没有显示出任何显著关系。我们建议对所有肥胖非糖尿病患者检测FBS和FIL以计算IR,这对IGT和糖尿病的发生有很大的启示。需要进行大型多中心纵向研究来确定IR的病因。